<VariationArchive VariationID="3640" VariationName="NM_020247.5(COQ8A):c.1813dup (p.Glu605fs)" VariationType="Duplication" Accession="VCV000003640" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2016-11-06" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18679" VariationID="3640">
      <GeneList>
        <Gene Symbol="COQ8A" FullName="coenzyme Q8A" GeneID="56997" HGNC_ID="HGNC:16812" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q42.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="226940294" stop="226987544" display_start="226940294" display_stop="226987544" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="227127937" stop="227175245" display_start="227127937" display_stop="227175245" Strand="+" />
          </Location>
          <OMIM>606980</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020247.5(COQ8A):c.1813dup (p.Glu605fs)</Name>
      <CanonicalSPDI>NC_000001.11:226986604:GG:GGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q42.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="226986604" stop="226986605" display_start="226986604" display_stop="226986605" variantLength="1" positionVCF="226986604" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="227174305" stop="227174306" display_start="227174305" display_stop="227174306" variantLength="1" positionVCF="227174305" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <OtherNameList>
        <Name>COQ8A, 1-BP INS, 1812G</Name>
        <Name>1812_1813insG</Name>
      </OtherNameList>
      <ProteinChange>E605fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.227174307dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.227174307dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.226986606dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.226986606dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012825.2" sequenceAccession="NG_012825" sequenceVersion="2" change="g.94071dup">
            <Expression>NG_012825.2:g.94071dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020247.5" sequenceAccession="NM_020247" sequenceVersion="5" change="c.1813dup" MANESelect="true">
            <Expression>NM_020247.5:c.1813dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_064632.2" sequenceAccession="NP_064632" sequenceVersion="2" change="p.Glu605fs">
            <Expression>NP_064632.2:p.Glu605fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1092" sequenceAccession="LRG_1092">
            <Expression>LRG_1092:g.94071dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1092t1" sequenceAccession="LRG_1092t1">
            <Expression>LRG_1092t1:c.1813dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1092p1" sequenceAccession="LRG_1092p1" change="p.Glu605fs">
            <Expression>LRG_1092p1:p.Glu605fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="606980.0005" DB="OMIM" />
        <XRef Type="rs" ID="387906298" DB="dbSNP" />
        <XRef ID="CA116403" DB="ClinGen" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020247.5(COQ8A):c.1813dup (p.Glu605fs) AND Autosomal recessive ataxia due to ubiquinone deficiency" Accession="RCV000003825" Version="13">
        <ClassifiedConditionList TraitSetID="956">
          <ClassifiedCondition DB="MedGen" ID="C2677589">Autosomal recessive ataxia due to ubiquinone deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-03-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2008-03-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-11-06" MostRecentSubmission="2022-10-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18319072</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">28125198</ID>
          <ID Source="BookShelf">NBK410087</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="956" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5960" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spinocerebellar ataxia, autosomal recessive 9</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Coenzyme Q10 deficiency, primary, 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive ataxia due to ubiquinone deficiency</ElementValue>
                <XRef ID="MONDO:0012784" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SCAR9</ElementValue>
                <XRef Type="MIM" ID="612016" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">COQ10D4</ElementValue>
                <XRef Type="MIM" ID="612016" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10294" />
                <XRef ID="10294" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Primary coenzyme Q10 (CoQ10) deficiency is usually associated with multisystem involvement, including neurologic manifestations such as fatal neonatal encephalopathy with hypotonia; a late-onset slowly progressive multiple-system atrophy-like phenotype (neurodegeneration with autonomic failure and various combinations of parkinsonism and cerebellar ataxia, and pyramidal dysfunction); and dystonia, spasticity, seizures, and intellectual disability. Steroid-resistant nephrotic syndrome (SRNS), the hallmark renal manifestation, is often the initial manifestation either as isolated renal involvement that progresses to end-stage renal disease (ESRD), or associated with encephalopathy (seizures, stroke-like episodes, severe neurologic impairment) resulting in early death. Hypertrophic cardiomyopathy (HCM), retinopathy or optic atrophy, and sensorineural hearing loss can also be seen.</Attribute>
                <XRef ID="NBK410087" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28125198</ID>
                <ID Source="BookShelf">NBK410087</ID>
              </Citation>
              <XRef ID="139485" DB="Orphanet" />
              <XRef ID="C2677589" DB="MedGen" />
              <XRef ID="MONDO:0012784" DB="MONDO" />
              <XRef Type="MIM" ID="612016" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23990" SubmissionDate="2019-09-20" DateLastUpdated="2019-09-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606980.0005_COENZYME Q10 DEFICIENCY, PRIMARY, 4" title="COQ8A, 1-BP INS, 1812G_COENZYME Q10 DEFICIENCY, PRIMARY, 4" />
        <ClinVarAccession Accession="SCV000023990" DateUpdated="2019-09-23" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1-bp insertion (1812insG) in the ADCK3 gene that was found in compound heterozygous state in a patient with cerebellar ataxia and seizures related to primary coenzyme Q10 deficiency-4 (COQ10D4; 612016) by Mollet et al. (2008), see 606980.0004.</Attribute>
              <Citation>
                <ID Source="PubMed">18319072</ID>
              </Citation>
              <XRef DB="OMIM" ID="612016" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COQ8A" />
          </GeneList>
          <Name>COQ8A, 1-BP INS, 1812G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1812G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606980.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">COENZYME Q10 DEFICIENCY, PRIMARY, 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="966434" SubmissionDate="2016-06-07" DateLastUpdated="2022-10-01" DateCreated="2016-11-06">
        <ClinVarSubmissionID localKey="NM_020247.4:c.1813dupG|OMIM:612016" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000494093" DateUpdated="2022-10-01" DateCreated="2016-11-06" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18319072</ID>
          </Citation>
          <Citation>
            <ID Source="BookShelf">NBK410087</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COQ8A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_064632.2:p.Glu605GlyfsTer125</Name>
            <Name>1812_1813insG</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020247.4:c.1813dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2677589" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="23990" TraitType="Disease" MappingType="Name" MappingValue="COENZYME Q10 DEFICIENCY, PRIMARY, 4" MappingRef="Preferred">
        <MedGen CUI="C2677589" Name="Autosomal recessive ataxia due to ubiquinone deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="966434" TraitType="Disease" MappingType="XRef" MappingValue="C2677589" MappingRef="MedGen">
        <MedGen CUI="C2677589" Name="Autosomal recessive ataxia due to ubiquinone deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

